Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience (Q45400010)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2007

Language	Label	Description	Also known as
English	Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience	scientific article published in October 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sheila F O'Brien

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Margaret A Fearon

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Qi-Long Yi

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Wenli Fan

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Vito Scalia

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Irene R Muntz

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Eleftherios C Vamvakas

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1809-1815

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Risks associated with transfusion of cellular blood components in canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Endpoints in clinical trials on transfusion requirements: the need for a structured approach.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Recent Canadian experience with targeted hepatitis C virus lookback

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Uses and sources of data on long-term survival after blood transfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01396.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2007.01396.X

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45400010&oldid=2076600127"